Stockreport

Nkarta Reports Third Quarter 2025 Financial Results and Corporate Highlights 

Nkarta, Inc.  (NKTX) 
PDF Enrollment now underway in second dose-escalation cohort Deep B-cell depletion observed in all patients treated to date who received NKX019 with lymphodepletion using fl [Read more]